Wall Street brokerages predict that Cardinal Health Inc (NYSE:CAH) will post $33.59 billion in sales for the current quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Cardinal Health’s earnings. The lowest sales estimate is $32.83 billion and the highest is $33.91 billion. Cardinal Health posted sales of $32.64 billion in the same quarter last year, which would indicate a positive year over year growth rate of 2.9%. The company is scheduled to issue its next quarterly earnings report on Monday, November 5th.

According to Zacks, analysts expect that Cardinal Health will report full-year sales of $140.60 billion for the current financial year, with estimates ranging from $138.92 billion to $141.71 billion. For the next fiscal year, analysts anticipate that the firm will post sales of $145.97 billion per share, with estimates ranging from $144.95 billion to $146.83 billion. Zacks’ sales averages are an average based on a survey of analysts that follow Cardinal Health.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Monday, August 6th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.93 by $0.08. Cardinal Health had a net margin of 0.19% and a return on equity of 22.59%. The company had revenue of $35.35 billion during the quarter, compared to analysts’ expectations of $34.38 billion. During the same period last year, the company posted $1.31 EPS. Cardinal Health’s revenue was up 7.2% on a year-over-year basis.

A number of research analysts recently issued reports on CAH shares. Royal Bank of Canada reissued a “hold” rating and set a $56.00 price target on shares of Cardinal Health in a research report on Tuesday, August 7th. Argus lowered their price target on shares of Cardinal Health from $85.00 to $75.00 and set a “buy” rating for the company in a research report on Monday, July 16th. Morgan Stanley lowered their price target on shares of Cardinal Health from $55.00 to $40.00 and set an “underweight” rating for the company in a research report on Tuesday, July 3rd. Mizuho restated a “hold” rating and set a $53.00 price objective on shares of Cardinal Health in a research note on Sunday, August 12th. Finally, Robert W. Baird restated a “hold” rating and set a $51.00 price objective on shares of Cardinal Health in a research note on Friday, July 20th. Three investment analysts have rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the stock. Cardinal Health has a consensus rating of “Hold” and a consensus price target of $62.31.

In other Cardinal Health news, CEO Jon L. Giacomin sold 2,890 shares of the firm’s stock in a transaction dated Monday, August 20th. The shares were sold at an average price of $51.95, for a total transaction of $150,135.50. Following the completion of the sale, the chief executive officer now directly owns 72,652 shares in the company, valued at approximately $3,774,271.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.97% of the stock is currently owned by company insiders.

A number of large investors have recently added to or reduced their stakes in CAH. Signaturefd LLC bought a new stake in shares of Cardinal Health in the first quarter worth approximately $100,000. Optimum Investment Advisors bought a new stake in shares of Cardinal Health in the first quarter worth approximately $128,000. Sentry Investment Management LLC bought a new stake in shares of Cardinal Health in the second quarter worth approximately $132,000. Mount Yale Investment Advisors LLC bought a new stake in shares of Cardinal Health in the first quarter worth approximately $136,000. Finally, Exane Asset Management bought a new stake in shares of Cardinal Health in the second quarter worth approximately $153,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

NYSE CAH traded down $0.23 during trading hours on Tuesday, reaching $54.94. 4,570,430 shares of the company’s stock traded hands, compared to its average volume of 2,838,697. Cardinal Health has a 52-week low of $48.14 and a 52-week high of $75.75. The stock has a market cap of $16.97 billion, a P/E ratio of 10.99, a price-to-earnings-growth ratio of 1.72 and a beta of 1.04. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.07 and a quick ratio of 0.53.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 15th. Shareholders of record on Monday, October 1st will be paid a dividend of $0.4763 per share. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.48. This represents a $1.91 dividend on an annualized basis and a yield of 3.47%. The ex-dividend date of this dividend is Friday, September 28th. Cardinal Health’s dividend payout ratio (DPR) is currently 38.20%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

Featured Article: How to Invest in Marijuana Stocks

Get a free copy of the Zacks research report on Cardinal Health (CAH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.